SS-31 Mechanism: Cardiolipin Binding and Mitochondrial Research

Research Use Only. The information presented here is for scientific and educational purposes. These compounds are not intended for human consumption, self-administration, or therapeutic use.

Introduction

SS-31 is a synthetic, mitochondria-targeted tetrapeptide widely used as a reference compound in laboratory studies of the inner mitochondrial membrane. First described by the researchers Hazel Szeto and Peter Schiller, it belongs to a family of aromatic-cationic peptides, the Szeto-Schiller (SS) series, engineered to concentrate inside mitochondria. In in-vitro and preclinical work, it is examined chiefly for how it interacts with cardiolipin, a signature phospholipid of the inner mitochondrial membrane.

The keyword phrase ss-31 mechanism points to a specific question in bioenergetics research: how does a four-residue peptide localize so selectively to mitochondria, and what happens at the cardiolipin interface once it arrives? The sections below outline the studied pathway, from membrane targeting and cardiolipin binding through the cytochrome c interaction, cristae architecture, electron transport, and reactive oxygen species. Every point reflects what has been observed in cell and animal models, not any human application. You can review the corresponding research compound on the SS-31 product page.

What Is SS-31?

SS-31 is a short peptide built from four amino acids arranged in an alternating pattern of aromatic and basic (positively charged) residues, a design that is central to its behavior at membranes. In published research, the same sequence has appeared under several names, including elamipretide and the code MTP-131, which can make the literature look broader than it actually is.

A mitochondria-targeted tetrapeptide

Unlike many charged molecules, SS-31 crosses the outer mitochondrial membrane and concentrates at the inner membrane, with reported accumulation of roughly a thousandfold or more relative to the surrounding cytosol. Importantly, this uptake is described as largely independent of the mitochondrial membrane potential, which distinguishes SS-31 from lipophilic-cation carriers that rely on the negative-inside voltage to accumulate. The values below reflect commonly reported laboratory attributes and are provided for comparison only.

Cardiolipin and the Inner Mitochondrial Membrane

Cardiolipin is an unusual phospholipid: it carries four acyl chains and two phosphate groups, effectively a dimer of the usual phospholipid unit. It is found almost exclusively in the inner mitochondrial membrane, where it makes up a substantial fraction of the lipid content and is concentrated in the tightly folded regions called cristae.

In cell-biology research, cardiolipin is a structural and functional organizer. Its cone-like geometry helps generate the curvature of cristae, it stabilizes the large respiratory chain complexes and their supercomplex assemblies, and it anchors cytochrome c to the membrane surface. Because so many bioenergetic processes converge on this single lipid, it is a focal point for compounds that interact with mitochondrial membranes, a theme seen in studies of peptides such as MOTS-c.

The Studied Mechanism: SS-31 at the Cardiolipin Interface

The core of the ss-31 mechanism literature concerns what happens when the peptide reaches cardiolipin, a connected sequence that researchers probe using isolated mitochondria, cultured cells, and animal models.

Binding and selective localization

Biophysical studies indicate that SS-31 associates with cardiolipin through electrostatic and hydrophobic contacts. The positively charged residues interact with the anionic phosphate headgroups, while the aromatic side chains, including the modified residue 2′,6′-dimethyltyrosine, insert toward the hydrophobic interior. Because cardiolipin is concentrated in the inner membrane, this affinity helps explain the peptide’s selective localization without any dependence on membrane voltage.

Cytochrome c and peroxidase activity

One of the most studied consequences involves cytochrome c. Under resting conditions it shuttles electrons within the respiratory chain, but when its interaction with cardiolipin shifts toward a peroxidase-like configuration, it can catalyze the peroxidation of cardiolipin, which researchers such as Valerian Kagan have characterized as an early step in mitochondrial injury. Laboratory reports describe SS-31 binding to cardiolipin in a way that limits this peroxidase activity while preserving the normal electron-carrier role of cytochrome c.

Cristae architecture and electron transport

By associating with cardiolipin, SS-31 is studied for its relationship to cristae structure. In various preclinical models, investigators have reported that peptide exposure is associated with better-preserved cristae and more efficient assembly of the electron transport chain, which in those models is linked to steadier ATP synthesis. These observations are laboratory endpoints measured in tissue and cell systems, not statements about any human outcome.

Reactive oxygen species and oxidative balance

Mitochondria are a major source of reactive oxygen species. Protecting cardiolipin from peroxidation and maintaining an organized electron transport chain are both associated, in the research literature, with lower excess ROS generation. This is why SS-31 is often grouped with longevity-oriented compounds studied in oxidative-stress models, alongside cofactor-based subjects such as NAD+.

SS-31 Compared With Other Mitochondrial-Targeting Strategies

SS-31 is not the only approach to reaching mitochondria in the laboratory; its distinguishing feature is the targeting logic. Many research compounds rely on a triphenylphosphonium (TPP+) cation that accumulates in response to membrane potential, whereas SS-31 targets a specific lipid. The following comparison reflects commonly reported laboratory attributes and is provided for comparison only.

This distinction matters in experimental design, because a cardiolipin-binding peptide can, in principle, localize even where membrane potential is reduced, as is often the case in stressed or damaged mitochondria.

Laboratory Handling and Quality Verification

SS-31 is supplied as a research compound for in-vitro and preclinical study only: research use only, not for human consumption. Purity and identity should be confirmed before any experiment. Our guide to reading a peptide COA explains what mass-spectrometry and HPLC values indicate, and our overview of how to choose a research peptide supplier covers sourcing practices.

Lyophilized peptides are typically reconstituted with an appropriate diluent; the bacteriostatic water reconstitution guide outlines handling, storage, and freeze-thaw considerations for short peptides like this tetrapeptide. None of this constitutes guidance for human or veterinary use.

Frequently Asked Questions

What is the mechanism of action of SS-31?

In laboratory research, SS-31 is a mitochondria-targeted tetrapeptide that concentrates in the inner mitochondrial membrane and binds the phospholipid cardiolipin. Studies focus on how this binding influences the cytochrome c interaction, cristae structure, and electron transport, not on any human outcome.

How does SS-31 bind cardiolipin?

SS-31 carries alternating aromatic and positively charged residues. Research suggests the cationic groups associate with the anionic phosphate headgroups of cardiolipin while the aromatic side chains insert into the lipid interface, giving the peptide selective affinity for the inner mitochondrial membrane.

What is cardiolipin and why does it matter in mitochondria?

Cardiolipin is a dimeric phospholipid with four acyl chains found almost exclusively in the inner mitochondrial membrane. In research it is studied for its role in shaping cristae, organizing respiratory chain complexes, and anchoring cytochrome c.

Is SS-31 the same as elamipretide?

In the research literature the same tetrapeptide appears under several designations, including SS-31, elamipretide, and MTP-131, all referring to the same aromatic-cationic sequence studied for its cardiolipin interaction.

How is SS-31 different from MitoQ?

Both are studied as mitochondria-targeted compounds, but their targeting differs. SS-31 binds cardiolipin and localizes largely independently of membrane potential, whereas MitoQ uses a triphenylphosphonium cation that accumulates in response to the mitochondrial membrane potential.

What molecular weight and sequence does SS-31 have?

SS-31 is commonly reported as the tetrapeptide D-Arg-Dmt-Lys-Phe-NH2 with the molecular formula C32H49N9O5 and an approximate molecular weight of 639.8 g/mol. These values are for laboratory comparison only.

References and Further Reading

1. Szeto HH and colleagues on the design and mitochondrial localization of Szeto-Schiller aromatic-cationic peptides. PubMed: Szeto SS-31 mitochondrial peptide
2. Studies of SS-31 and elamipretide binding to cardiolipin in the inner mitochondrial membrane. PubMed: SS-31 cardiolipin binding
3. Kagan and coworkers on cardiolipin, cytochrome c, and peroxidase activity. PubMed: cardiolipin cytochrome c peroxidase
4. Reviews of cardiolipin in cristae architecture and respiratory supercomplex organization. PubMed: cardiolipin cristae respiratory supercomplex
5. Preclinical investigations of elamipretide in mitochondrial dysfunction models. PubMed: elamipretide mitochondrial dysfunction
6. Murphy and colleagues on mitochondria-targeted compounds and TPP+ conjugates. PubMed: mitochondria-targeted antioxidant MitoQ
7. General reviews of mitochondria-targeted peptides in aging and bioenergetics research. PubMed: mitochondria-targeted peptide bioenergetics